MAS1L and Cerebral ischemia: Therefore, is unclear to what extent the protective effects of Ang (1–7) might have been mediated by the MasR, and it remains to be determined whether selective MasR activation represents a therapy that can independently elicit neuroprotection in cerebral ischemia.